Navigation Links
Wall's To Develop Low-fat Ice-cream Using Fish Blood

Wall's have announced their plans to use a protein that has been originally isolated from fish blood to produce the world's first ice creams using genetically// modified technology.

The parent company, Unilever, have claimed that the technique will allow it them to develop ice creams that are of low-calorie, and low fat. They explained that they could be using this technology to make newer versions of their best selling products like the Cornetto, Magnum, and Carte D'Or.

There are debates going on about the GM technology due to an increased desire by consumers for a more natural 'real' food diet, where in artificial additives are removed. But officials at the Unilever believe the benefits of low-fat ice cream could prevail over any doubts about GM.

It was explained that the blood protein is originally extracted from an eel-like ocean pout fish, which uses the protein to survive extreme cold at the bottom of the seas. They stated that the protein has been chemically synthesised and it can be grown in vast vases that can produce a brownish liquid. This liquid, they explained could lower the lowers the temperatures at which ice crystals form and the shape they take up. They claimed that they could then create a stiff and solid mixture by using less cream or fat.

The company has also announced that they have submitted an application with the Food Standard Agency to use the new technology, involving the GM process. Unilever officials have also stated that the process has already been approved in the U.S. and in other parts of the world. They categorically stated that no GM material would remains in the final product, and that the process involving the GM element would be used to only create the protein.

Clare Oxborrow a food campaigner of the Friends of the Earth has said: 'At a time when more and more consumers want to choose unadulterated food, it's disappointing to see Unilever investing in this unnecessa ry development in overly processed food.'


'"/>




Related medicine news :

1. Developmental, neurologic problems common in extremely preterm infants
2. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
3. Risk Of Developing Arthritis
4. Developing HIV fighter
5. Missing Protein In Cancer Development
6. Tomatoes Might Inhibit the Development Of Prostate Cancer
7. Antibiotics Found To Increase The Risk Of Developing Breast Cancer
8. The Effectiveness Of Cancer Drug In Women At Risk Of Developing Cancer
9. Men Who at Risk Of Developing Prostate Cancer
10. Identifying The Risks Of Developing Schizophrenia
11. Patients With Severe Hemophilia At Risk Of Developing Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2017)... ... 22, 2017 , ... Happy Living’s mission - to improve the health and ... the entertaining and delicious worlds of theatre and wines. , After watching Scott ... to turn his play into a book. The Greener The Grass ( https://www.happyliving.com/books/the-greener-the-grass ) ...
(Date:9/22/2017)... ... , ... "Success Files," a short- and long-form documentary style ... disease estimated to affect the lives of more than 5 million Americans living ... leading voice in the fight for cure and research into the disease, its ...
(Date:9/22/2017)... ... September 22, 2017 , ... Egg ... life. Although frozen embryos have a slight statistical advantage for live births, frozen ... a wonderful opportunity for women undergoing medical treatment or who are concerned about ...
(Date:9/21/2017)... , ... September 21, 2017 , ... SABRE is raising ... from September 11 to the end of November. , The Chicago, Illinois, based self-defense ... community and teach them about the ease of taking their personal safety into their ...
(Date:9/21/2017)... ... 2017 , ... Bill Howe Plumbing’s mission is to create an employee friendly ... community. For over 37 years, they have operated with their mission at the foundation ... San Diego. They were chosen as the Best San Diego plumber in 2016, named ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... Sept. 9, 2017  Eli Lilly and Company (NYSE: ... secondary endpoint data for lasmiditan, an investigational, oral, first-in-class ... statistically significant improvements compared to placebo in the Phase ... at the 18th Congress of the International Headache Society ... "The data presented today demonstrate lasmiditan,s potential to reduce ...
(Date:9/7/2017)... RANCHO MIRAGE, Calif. , Sept. 7, 2017  For nearly two ... and service in the Assisted Reproduction Insurance industry. Today, New Life Agency ... expensive fertility medications. ... http://pharmacarecard.com/ (PRNewsfoto/PharmaCareCard) ... ...
(Date:9/7/2017)... , Sept. 7, 2017 NuvoAir ... Smart Spirometer, announced today a partnership with Novartis Pharma AG ... solidifies NuvoAir,s position as the leading mobile spirometry platform and ... patients. ... test ...
Breaking Medicine Technology: